Drug · DIN 02457016
TADALAFIL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 8, 2021; first marketed July 8, 2021.
- Drug Identification Number (DIN)
- 02457016
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tadalafil G04BE08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TADALAFIL | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 13, 2016: NOC 18475Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named TADALAFIL
- DIN 02455358 · Marketed
- DIN 02455366 · Marketed
- DIN 02455374 · Marketed
- DIN 02457024 · Marketed
- DIN 02457032 · Marketed
- DIN 02536676 · Marketed
- DIN 02536684 · Marketed
- DIN 02536692 · Marketed
- DIN 02536706 · Marketed
- DIN 02441098 · Approved
- DIN 02441101 · Approved
- DIN 02441128 · Approved
- DIN 02441136 · Approved